FerrazzoliD, Carter A,UstunFS, et al. Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinsons Disease: Implications for Rehabilitation. FrontBehavNeurosci. 2016;10. doi:10.3389/fnbeh.2016.00121 January 17, 2022 Read More
FrazzittaG,MaestriR,BertottiG, et al. Intensive rehabilitation treatment in early Parkinsons disease: A randomized pilot study with a 2-year follow-up.NeurorehabilNeuralRepair. 2015;29(2):123-131. doi:10.1177/1545968314542981 January 17, 2022 Read More
Ho AL, Ali R, Connolly ID, et al. Awake versus asleep deep brain stimulation for Parkinsons disease: a critical comparison and meta-analysis.J NeurolNeurosurgPsychiatry. 2018;89(7):687-691. doi:10.1136/jnnp-2016-314500 January 17, 2022 Read More
Lee DJ, Lozano AM. The Future of Surgical Treatments for Parkinsons Disease.BrundinP, Langston JW,BloemBR, eds.JParkinsonsDis. 2018;8(s1):S79-S83. doi:10.3233/JPD-181467 January 17, 2022 Read More
Lin F, Wu D, Yu J, et al. Comparison of efficacy of deep brain stimulation and focused ultrasound in parkinsonian tremor: a systematic review and network meta-analysis. J NeurolNeurosurgPsychiatry. 2021 Jan 18:jnnp-2020-323656.doi: 10.1136/jnnp-2020-323656. January 17, 2022 Read More
Lorente-PicnM, Laguna A. New Avenues for Parkinsons Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota.Biomolecules. 2021;11(3):433. doi:10.3390/biom11030433 January 17, 2022 Read More
Martnez-Fernndez R,Mez-Mir JU, Rodrguez-Rojas R, et al. Randomized Trial of Focused UltrasoundSubthalamotomyfor Parkinson’s Disease. NEnglJ Med. 2020 Dec 24;383(26):2501- 2513.doi: 10.1056/NEJMoa2016311. January 17, 2022 Read More
Perlmutter J,UsheM. Parkinson’s Disease – What’s the FUS? NEnglJ Med. 2020 Dec 24;383(26):2582-2584.doi: 10.1056/NEJMe2031151. January 17, 2022 Read More
Rowe JB, et al. Parkinsons disease and dopaminergic therapy–differential effects on movement, reward and cognition.Brain2008; 131:2094-2105. January 17, 2022 Read More
